Genetic testing
A
prospective study on predictive factors linked to the presence of BRCA1 and BRCA2 mutations
in breast cancer patients
Carla C. Wárlám-Rodenhuis, Veronica C.M. Koot, Rob B. van
der Luijt, Hans F.A. Vasen and Margreet G.E.M. Ausems.
European Journal of Cancer . Volume 41,
Issue 10: p. 1409-1415, July 2005.
BRCA1
variants in a family study of African-American and Latina women
Roberta McKean-Cowdin, Heather Spencer Feigelson, Lucy Y. Xia, Celeste
Leigh Pearce, Duncan C. Thomas, Daniel O. Stram and Brian E. Henderson.
Human Genetics. Volume 116, Number 6:
p. 497-506, May, 2005.
Classification
of BRCA1 missense variants of unknown clinical significance
C M Phelan, V api, B Tice, R Favis, E Kwan, F Barany, S Manoukian, P Radice,
R B van der Luijt, B P M van Nesselrooij, G Chenevix-Trench, kConFab, T Caldes,
M de La Hoya, S Lindquist, S V Tavtigian, D Goldgar, Å Borg, S A Narod
and A N A Monteiro.
Journal of Medical Genetics. Volume 42, Number
2: p. 138-146, May 2005.
Racial
differences in the use of BRCA1/2 testing among women with a family history
of breast or ovarian cancer
Katrina Armstrong, MD, MSCE; Ellyn Micco, BA; Amy Carney, BA; Jill Stopfer,
MS; Mary Putt, ScD
Journal of the American Medical Association. Volume 293, Number
14: p. 1729-1736.
Knowledge,
attitudes, and utilization of BRCA1/2 testing among women with early-onset
breast cancer
Peters N, Domcheck SM, Rose A, Polis R, Stopfer J, Armstrong K.
Genetic Testing. Volume 9, Number 1: p. 48-53,
March 2005.
Functional
evaluation and cancer risk assessment of BRCA2 unclassified variants
Kangjian Wu, Shannon R. Hinson, Akihiro Ohashi, Daniel Farrugia, Patricia
Wendt, Sean V. Tavtigian, Amie Deffenbaugh, David Goldgar and Fergus J. Couch.
Cancer Research. Volume 65, Number 2: p.
417-426, January 2005.
Integrated
evaluation of DNA sequence variants of unknown clinical significance: application
to BRCA1 and BRCA2
David E. Goldgar, Douglas F. Easton, Amie M. Deffenbaugh, Alvaro N. A.
Monteiro, Sean V. Tavtigian, Fergus J. Couch, and the Breast Cancer Information
Core (BIC) Steering Committee.
American Journal of Human Genetics. Volume
75, Number 4: p. 535-544, October 2004.
Prevalence
of BRCA1 and BRCA2 germline mutations in young breast cancer patients:
A population-based study
Silvia de Sanjosé, Mélanie Léoné, Victoria
Bérez, Angel Izquierdo, Rebeca Font, Joan M. Brunet, Thierry Louat,
Loreto Vilardell, Joan Borras, Pau Viladiu, F. Xavier Bosch, Gilbert M. Lenoir,
Olga M. Sinilnikova.
International Journal of Cancer. Volume 106, Issue 4: p. 588 - 593,
September 2003.
Psychosocial
redictors of BRCA ounseling and testing Decisions among urban African-American
women
Hayley S. Thompson, Heiddis B. Valdimarsdottir, Chantal Duteau-Buck, Josephine
Guevarra, Dana H. Bovbjerg, Cassandra Richmond-Avellaneda, David Amarel,
Diana Godfrey, Karen Brown and Kenneth Offit. Cancer
Epidemiology Biomarkers & Prevention. Volume 11: p. 1579-1585, December
2002.
What
do ratings of ancer-specific distress mean among women at high risk of
breast and ovarian cancer?
James C. Coyne, Linda Kruus, Melissa Racioppo, Kathleen A. Calzone, Katrina
Armstrong. American Journal of Medical Genetics.
Volume 116A, Issue 3: p. 222-228, September 2002.
Clinical characteristics
of individuals with germline mutations in BRCA1 and BRCA2: Analysis of
10,000 individuals
Thomas S. Frank, Amie M. Deffenbaugh, Julia E. Reid, Mark Hulick, Brian E.
Ward, Beth Lingenfelter, Kathi L. Gumpper, Thomas Scholl, Sean V. Tavtigian,
Dmitry R. Pruss, Gregory C. Critchfield. Journal
of Clinical Oncology. Volume 20, Issue 6: p. 1480-1490, March 2002.